Improving Outcomes With PARP Inhibitors in Ovarian Cancer

Join the experts for this online activity on PARP inhibitors in ovarian cancer featuring interactive case vignettes and dynamic in-page polling questions and 2 podcasts all linked to a downloadable slideset.

This educational program  is intended for clinicians practicing medicine outside of the United States.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Supporters

GlaxoSmithKline LLC